Roundtable Discussion: Navigating Existing Standards & Regulatory Requirements for Analytical Development of mRNA Vaccines to Ensure a Streamlined Approval
Time: 9:30 am
day: Conference Day One
Details:
- Delving into the quality issues regarding mRNA vaccines and how we can overcome them
- Discussing what is expected by the regulatory agencies for the clinical and non-clinical requirements
- Understanding the regulatory guidelines for CMC’s and manufacturing testing to allow a streamline approval
- Exploring the advances of having a platform approach for vaccines to allow a more rapid approval of your mRNA vaccines
